Post-prandial lipid effects of raltegravir versus darunavir/ritonavir in HIV-1-infected adults commencing combination ART. (18th December 2015) - Lee, F. J.; Marriott, D.; Bloch, M.; Richardson, R.; Mackenzie, N.; Carr, A.